TABLE 2.
Median lengths of time, in weeks, for drug approval process for Atlantic Canada provinces, by year*
| CDR Submission – CDR recommendation | σ | CDR Recommendation – Provincial formulary | σ | Total | ||
|---|---|---|---|---|---|---|
| New Brunswick | ||||||
| 2005 | 20.3 | 1.9 | 45.1 | 22.7 | 65.4 | |
| 2006 | 21.9 | 6.4 | 31.9 | 12.6 | 53.8 | |
| 2007 | 24.1 | 10.0 | 22.0 | 8.1 | 46.1 | |
| Nova Scotia | ||||||
| 2005 | 20.3 | 1.9 | 6.9 | 7.0 | 27.2 | |
| 2006 | 21.9 | 6.4 | 18.6 | 32.9 | 40.5 | |
| 2007 | 24.1 | 10.0 | 12.1 | 12.9 | 36.2 | |
| Newfoundland & Labrador | ||||||
| 2005 | 20.3 | 1.9 | 10.1 | 36.5 | 30.4 | |
| 2006 | 21.9 | 6.4 | 35.9 | 21.4 | 57.8 | |
| 2007 | 24.1 | 10.0 | 13.5 | 13.6 | 37.6 | |
| Prince Edward Island | ||||||
| 2005 | 20.3 | 1.9 | 125.1 | 39.7 | 145.4 | |
| 2006 | 21.9 | 6.4 | 76.6 | 27.6 | 98.5 | |
| 2007 | 24.1 | 10.0 | 44.1 | 16.0 | 68.2 | |
*
Based on information for 35 drugs with a recommendation of “List,” “List with criteria/conditions” and “list in a similar manner to other drugs in class” issued between January 1, 2005 and May 1, 2008.